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temperature gradient and cooling rate, and 4) peak warming
temperature gradient and rewarming rate. Authors adopted the
American College of Cardiology/American Heart Association
method for development clinical practice guidelines, and arrived
at the following recommendation. Keywords: cardiopulmonary
bypass, perfusion, temperature management, cardiopulmonary
bypass neurologic morbidity. JECT. 2015;47:145–154

Abstract: To improve our understanding of the evidence-based
literature supporting temperature management during adult cardiopulmonary bypass, The Society of Thoracic Surgeons, the Society
of Cardiovascular Anesthesiology and the American Society of
ExtraCorporeal Technology tasked the authors to conduct a review
of the peer-reviewed literature, including 1) optimal site for temperature monitoring, 2) avoidance of hyperthermia, 3) peak cooling

CLASS I RECOMMENDATIONS
1. The oxygenator arterial outlet blood temperature is recommended to be used as a surrogate for cerebral tem-
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perature measurement during cardiopulmonary bypass
(CPB). (Class I, Level C)
To monitor cerebral perfusate temperature during
warming, it should be assumed that the oxygenator arterial outlet blood temperature underestimates cerebral
perfusate temperature. (Class I, Level C)
Surgical teams should limit arterial outlet blood temperature to <37 C to avoid cerebral hyperthermia. (Class I,
Level C)
Temperature gradients between the arterial outlet and
venous inflow on the oxygenator during CPB cooling
should not exceed 10 C to avoid generation of gaseous
emboli. (Class I, Level C)
Temperature gradients between the arterial outlet and
venous inflow on the oxygenator during CPB rewarming
should not exceed 10 C to avoid outgassing when blood
is returned to the patient. (Class I, Level C)
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CLASS IIA RECOMMENDATIONS
1. Pulmonary artery (PA) or nasopharyngeal temperature
recording is reasonable for weaning and immediate postbypass temperature measurement. (Class IIa, Level C)
2. Rewarming when arterial blood outlet temperature ³30 C:
i. To achieve the desired temperature for separation
from bypass, it is reasonable to maintain a temperature gradient between arterial outlet temperature and
the venous inflow of £4 C. (Class IIa, Level B)
ii. To achieve the desired temperature for separation
from bypass, it is reasonable to maintain a rewarming
rate £ .5 C/min. (Class IIa, Level B)
3. Rewarming when arterial blood outlet temperature
<30 C: to achieve the desired temperature for separation
from bypass, it is reasonable to maintain a maximal gradient of 10 C between arterial outlet temperature and
venous inflow. (Class IIa, Level C)
NO RECOMMENDATION
No recommendation for a guideline is provided concerning optimal temperature for weaning from CPB due
to insufficient published evidence.
Numerous strategies are currently invoked by perfusion
teams to manage the requirements of cooling, temperature
maintenance, and rewarming patients during cardiac surgical procedures. To date there have been very few evidencebased recommendations for the conduct of temperature
management during perfusion. Although Bartels et al.
(1) found no supporting evidence for an evidence-based
guideline for managing the temperature gradient during
CPB, Shann et al. (2) recommended that “limiting arterial
line temperature to 37 C might be useful for avoiding cerebral hyperthermia,” including checking “coupled temperature” ports for all oxygenators for accuracy and calibration
(Class IIa, Level B).
Owing to differences in interpreting the literature and the
paucity of published guidelines in this clinical area, there is
extensive variability in the conduct of managing perfusate
temperature during CPB. A recent survey of perfusionists
found that 1) in more than 90% of centers, mildly hypothermic perfusion of 32 C to 34 C is routinely used and 63%
achieve that temperature without active cooling; 2) during
CPB, the most common sites for measuring temperature are
nasopharyngeal (NP, 84%), venous return (75%), arterial
line (72%), bladder (41%), and rectum (28%); 3) 19% of
centers reported routinely calibrating their in-line temperature probes; and 4) 44% of centers exceed the 37 C peak
temperature limit for the arterial line temperature during
rewarming (3). Although temperature management strategies are frequently reported in the literature, the rationale
for these practices is often underreported or absent.
JECT. 2015;47:145–154

To improve our understanding of the evidence-based
literature supporting temperature management, we conducted a review of the peer-reviewed literature, including
1) optimal site for temperature monitoring, 2) avoidance
of hyperthermia, 3) peak cooling temperature gradient
and cooling rate, and 4) peak warming temperature gradient and rewarming rate.
MATERIALS AND METHODS
Literature Search
We used a systematic search of Medical Subject Heading
terms to identify peer-reviewed articles related to temperature management in the setting of adult CPB (Appendix).
Candidate articles were published in PubMed between
January 1, 2000 and March 31, 2014. Our search revealed
768 abstracts, all of which were reviewed in duplicate by
independent reviewers, with 153 abstracts selected for full
paper review. To be included, each paper had to report
data on each of the following: 1) optimal site for temperature monitoring, 2) avoidance of hyperthermia, 3) peak
cooling temperature gradient and cooling rate, and 4) peak
warming temperature gradient and rewarming rate.
According to American College of Cardiology/American
Heart Association (ACC/AHA) rules (Table 1), any reviewer
could select an abstract for inclusion in a paper review, but
at least two reviewers had to agree to exclude a paper (4).
At the paper review stage, at least two reviewers had to
agree to exclude a paper. These rules were incorporated
into Guideliner reviewing software (www. guideliner.org/
default.aspx, accessed May 20, 2014). Thirteen articles considered relevant to the topic by the authors were included
to provide method, context, or additional supporting evidence for the recommendations.
RESULTS
Synthesizing the Evidence
Two reviewers rejected 615 abstracts based on a lack
of relevance, leaving 153 abstracts for full paper review
(Figure 1). Two panel members reviewed each paper, and
82 of these papers were found not to contribute to the
topic by both reviewers, a further 32 had conflicting reviews
and were individually resolved, and the final 39 were considered for inclusion in the guideline. Of the additional
13 articles relevant to the development of the Guideline 8
predated 2000.
Optimal Site for Temperature Measurement
A number of sites for routine core and cerebral temperature management have been reported, including NP, tympanic membrane, bladder, esophagus, rectum, PA, jugular
bulb (JB), arterial inflow, and venous return (3). A single,
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Table 1. American College of Cardiology/American Heart Association: Classifications and level of evidence (4).
Classification
Class I
Class II
Class IIa
Class IIb
Class III

Level of evidence
Level A
Level B
Level C

Clinical recommendation
Benefit >>> risk
Conditions for which there is evidence and/or general agreement that a given procedure or treatment is
useful and effective
Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy
of a procedure or treatment. This is classified as IIa or IIb
Benefit >> risk
Weight of evidence/opinion is in favor of usefulness/efficacy
Benefit ³ risk
Usefulness/efficacy is less well established by evidence/opinion
Risk ³ benefit
Conditions for which there is evidence and/or general agreement that the procedure/treatment is not useful/effective
and in some cases may be harmful. This is defined as: no benefit—procedure/test not helpful or treatment without
established proven benefit; harm—procedure/test/treatment leads to excess cost without benefit or is harmful
Type of evidence
Evidence from multiple randomized trials or meta-analyses
Evidence from single randomized trial or nonrandomized studies
Evidence from expert opinion, case studies, or standard of care

easily monitored, optimal core temperature site has not been
reported, although the intravascular and intracorporeal location of a PA catheter probably renders this site the best access
for core temperature recording. However, PA catheters are
used infrequently in many centers, necessitating a different
core temperature measurement site. The measurement of
the JB temperature is recognized as being the best indicator
of cerebral temperature (5,6), but it is not routinely used as
a monitor and its accuracy depends on the optimal positioning of this invasive temperature probe (6).
Akata et al. (7), in a study to evaluate monitoring of
brain temperature during deep hypothermic circulatory
arrest, compared five sites with JB monitoring. The authors
recommended the use of PA and NP locations for estimating cerebral temperature rather than forehead, bladder, and
fingertip sites. Bladder and rectal temperatures are unreliable indicators of cerebral temperature during CPB and
may be as much as 2 C to 4 C lower than the brain temperature when rewarming during CPB (6). Thus, use of NP
temperature monitoring is preferable to bladder or rectal
temperatures during rewarming to avoid potential cerebral
hyperthermia (8–10).

Figure 1. Flowchart illustrates the pathway of abstracts identified by the
search strategy. Literature has been included in final selection (included)
from various levels of the review process, including 13 papers not identified in the original search strategy.

Johnson et al. (11) highlighted, in a prospective study of
80 patients, the disparity in temperature measurement
between the NP temperature and the arterial outlet temperature. In 2004, Kaukuntla et al. (12) demonstrated that
commonly used core temperature monitoring sites (bladder,
esophageal, and NP) were not accurate measures of cerebral temperature where JB temperature is used as the gold
standard. The authors concluded that arterial outlet temperatures should be monitored to avoid cerebral hyperthermic inflow. Nussmeier et al. (6,8) demonstrated that arterial
blood outlet temperature measurement provided the best
correlate with JB temperature, followed by NP and esophageal locations. Nussmeier et al. (6) also demonstrated that all
body sites overestimated JB temperature during cooling and
underestimated JB temperature during rewarming, reporting that, “the arterial outlet site had the smallest average
discrepancy of all temperature sites relative to the JB site.”
The accuracy of arterial blood outlet–coupled temperature ports has been reported in clinical and in vitro studies
(13–16). These studies have consistently demonstrated variation between the temperature measured at the arterial
outlet and a reference temperature measurement (a temperature probe placed distally within the circuit). Newland
et al. (14) measured the arterial outlet temperature accuracy
in four different oxygenators and reported that at 37 C, the
arterial outlet temperature measurement underestimated
the reference thermometer temperature by between .33 C
and .67 C. These studies suggest that the maximum arterial
blood outlet temperature target should be lower than 37 C
to avoid perfusing the patient with blood temperatures
higher than 37 C. Such corrections must be considered
when using arterial outlet temperature as a surrogate site
to monitor cerebral temperature.
After equilibration of core temperature after CPB, bladder temperature has been recommended as a good, noninvasive approach for monitoring core temperature (17).
JECT. 2015;47:145–154
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Bladder temperature probes have been shown to be reliable
and correlate well with PA catheters in reflecting core body
temperature in children (18). Khan et al. (19) demonstrated
that tympanic membrane and axillary temperature measurements did not accurately reflect bladder temperature
after CPB and suggested that clinical decisions should not
be based on the former two temperature measurements.
Recommendation:
1. The oxygenator arterial outlet blood temperature is recommended to be used as a surrogate for cerebral temperature measurement during CPB. (Class I, Level C)
2. To accurately monitor cerebral perfusate temperature
during warming, it should be assumed that the oxygenator arterial outlet blood temperature underestimates
cerebral perfusate temperature. (Class I, Level C)
3. PA or NP temperature recording is reasonable for core
temperature measurement. (Class IIa, Level C)
Avoidance of Hyperthermia
Avoidance of cerebral hyperthermia in the setting of CPB
has been promoted to avoid cerebral injury (10,12,20–22).
Scheffer and Sanders (10) highlight that although the independent relationship between cerebral hyperthermia during
CPB and neurologic injury has not been unequivocally
proven, sufficient and compelling indirect evidence supports extreme caution. Shann et al. (2) applied evidence
from the stroke literature to support a recommendation
to limit the arterial blood outlet temperature to 37 C to
avoid cerebral hyperthermia. Several reports have noted
the association of increased cerebral temperature and rapid
CPB rewarming with JB desaturation (23–25). Numerous
authors have suggested that cerebral temperatures higher
than 37 C should be avoided at any time during the
rewarming phase of CPB and that this may be performed
by careful monitoring and maintenance of arterial blood
outlet temperatures lower than 37 C (15,20–22,26).
Grocott et al. (27) evaluated the effect of intraoperative temperature management in a randomized trial of
300 patients and found that the maximum postoperative
temperature was weakly associated with increased cognitive dysfunction at 4–6 weeks. Hyperthermia has also been
reported to influence other outcomes after cardiac operations. Groom et al. (28) reported an association with hyperthermia (defined as a peak core temperature >37.9 C) and
an increased rate of mediastinitis. Newland et al. (29)
reported in 2013 that an arterial outlet temperature exceeding 37 C during CPB is an independent predictor of acute
kidney injury.
Recommendation:
Surgical teams should limit arterial outlet blood temperature to less than 37 C to avoid cerebral hyperthermia.
(Class I, Level C)
JECT. 2015;47:145–154

Peak Cooling Temperature Gradient and Cooling Rate
In 1997, Geissler et al. (30) demonstrated that temperature gradients (differential temperature between arterial
outlet and venous inflow blood temperature) on cooling of
more than 10 C were associated with gas emboli formation.
They also reported no gaseous microemboli production
when rapid cooling was used; however, this finding has not
been reproduced. No contemporary literature has addressed
this issue; however, a unique study in dogs in 1964 by
Almond et al. (31) documented severe brain injury when
an arterial-venous gradient of 20 C was used for cooling
and significantly less injury when the cooling gradient was
limited to 4 C. The authors proposed that rapid, high gradient cooling might not provide adequate cerebral hypothermia, preventing cerebral protection during induced cardiac
arrest (the usual approach to cardiac operations in that era).
Recommendation:
Temperature gradients between the arterial outlet and
venous inflow on the oxygenator during CPB cooling
should not exceed 10 C to avoid generation of gaseous
emboli. (Class I, Level C)
Peak Warming Temperature Gradient and
Rewarming Rate
The rate of rewarming during CPB and the temperature
gradient to achieve this rewarming goal produces a conundrum for clinicians: the team must balance the deleterious
effects of an extended duration of CPB and operative times
with those that may be associated with rapid rewarming
rates. A seminal issue has related to the potential for
outgassing when warm blood is returned to the hypothermic
patient, because dissolved gases come out of the blood when
rapid rewarming takes place. Outgassing may be prevented
by maintaining a maximal 10 C gradient between the arterial blood outlet and the venous inlet blood temperature
(32). A number of studies have evaluated rewarming and
temperature gradients, with a recommended gradient of not
more than 10 C being most commonly reported (Table 2).
Five clinical studies reported the influence of the rewarming rate (Table 3). Grigore et al. (45), in a cohort study
evaluating cognitive performance of patients post-CPB,
demonstrated a benefit associated with “slow” rewarming
compared with “rapid” rewarming in the post-CPB cognitive performance of patients. In this study, slow rewarming
(.49 C ± .17 C/min) was achieved with a maximal gradient
of 2 C between the NP temperature and the CPB arterial
blood outlet temperature, whereas rapid rewarming (.56 C ±
.22 C/min) was achieved with a 4 C to 6 C maximal gradient.
The slow rewarming group also avoided some of the exposure to excess hyperthermia and had temperatures in excess
of 37 C for shorter periods. In this study, the gradient
driving rewarming was between the NP temperature and
the arterial blood outlet temperature. Borger and Rao (43)
reported an observational study in which patients were

Prospective,
randomized

Prospective,
randomized
Prospective,
randomized

Ginsberg (33)

Nathan (34)

Prospective,
randomized
Prospective,
randomized
Prospective
observational
1393

80

223/267

20

103

30

267

NA
12/30

60

60

30

80

223

101

8

10

133

Number

NR

.33 C/min

2–4 C
NR

<1 C/min



Varying,
as high as
20–25 C
NR

NR



NR

H/E to blood

37.5 C/37 C

NP

NP

NP

37.5 C/34.5 C
NR

JB cooling, bladder rewarming

37.5 C
JB to H/E
NR

NR

NR

NR (“CPB temperature” perhaps
arterial blood outlet)
NP (hypothermic), bladder
(normothermic)
NP, arterial line temperature?
JB, NP, esophageus, bladder,
rectum, arterial blood outlet
NP

37 C

NR

37.5 C/34.5 C

NR
37 C

37.5 C

NR

NP cooling, bladder rewarming

NP

38 C

Thermodilution catheter
placed in superior vena cava,
arterial blood outlet (oxygenator)
PA catheter thermistor

NP

37–39 C

Monitoring site driving
temperature management

NP, venous return

NP

NR

NR

NR

NR

NR

Max arterial
outlet

NR

H/E to venous

10 C

NR

NR

1 C every
5 minutes
NR

NR

NR

H/E to arterial
inlet?
NR
NR

NR

NR
NR

.2 C/min
NR
N/A

10 C

NR

NR

H/E to venous
H/E to venous

5 C
10 C

NR



NR

NR

H/E to venous

NR

NR

NR

<10 C

Venous and
arterial blood

0 C, 5 C, 10 C,
15 C, 20 C

1 C every
3–5 minutes,
achieved
.2 C ± .09 C,
.19 C ± .07 C,
.18 C ± .07 C
NR

H/E to blood

10 C

.56 C/min
(estimated)†
NR

NR

Gradient
between

NR

Temperature
gradient ( C)

NR

Rewarming rate
( C/min)

*A description of reported trials (patient and animal) on rates of rewarming and arterial-venous temperature gradients (1992–2013).
†Calculated, not stated in original publication. H/E, heat exchanger; NR, not reported.

Newland (29)

Sahu (42)

Boodhwani (41)

Akata (7)

Hong (40)

Rasmussen (39)

Boodhwani (38)

Nussmeier (8)
Nussmeier (6)

Kaukuntla (12)

Ali (37)

Schmid (35)
Lindholm (36)

Johnson (11)

Geissler (30)

Prospective,
randomized
Prospective,
randomized
Prospective,
randomized
Review
Prospective
observational
Prospective,
randomized
Prospective,
randomized
Prospective
observational
Prospective
observational

Prospective
observational
Prospective
observational
Animal

Croughwell (25)

Cook (23)

Study design

First author

Table 2. Rewarming rates and temperature gradients.*

CLINICAL PRACTICE GUIDELINES FOR CARDIOPULMONARY BYPASS
149

JECT. 2015;47:145–154

JECT. 2015;47:145–154

RCT

Prospective
cohort blinded

RCT

RCT

Diephuis 2002 44

Grigore 2002 45

Kawahara 2003 46

Saleh 2005 47
30

100

165

50

146

10

No.

NR
5
2
1–2

3

.24 C ± .08 C/min
.49 C ± .17 C/min
.24 C/min

.196 C ± .016 C/min

NR

Gradient

30 ± 9 min

.45 C/min
(estimated)b



Rate/duration

.34 C ± .027 C/min

.48 C/min

.56 C ± .22 C/min

.5 C ± .36 C/min

15 ± 4 min

.71 C/min
(estimated)b



Rate/duration

7

4–5

4–6

10

NR

NR

Gradient

Fast Rewarming

NP to H/E

Tympanic and
arterial outlet

NP and arterial
outlet

NP to H/E

H/E to blood

Gradient
between

NR

NR

NR

NR

Max
arterial
outlet

NP

Tympanic, PA

NP

NP

NP

NP

Monitoring site
driving
temperature
management

Cerebral venous oxygen
desaturation less in
slow group
Neurocognitive function,
benefit with slower
rewarming rate
Cerebral pressure flow
index unaffected by
rewarming rate
Neurocognitive function,
benefit with slower
rewarming rate
Jugular venous oxygen
hemoglobin saturation,
less decrease with
slower rewarming rate
Cardiac performance
(cardiac index and peak
velocity), blood lactate
level, early homeostasis,
ICU stays, improved
with slower rewarming
(medium rate,
.248 C ± .023 C)

Outcome measure

Abbreviations: H/E = heat exchanger; ICU = Intensive care unit; NP = nasopharyngeal; NR = not reported; PA = pulmonary artery; RCT = randomized controlled trial.
a
A description of reported trials (patients only) specific to slow vs. fast rewarming rates, arterial-venous gradients, and outcomes (1996–2005).
b
Calculated, not stated in original publication.

Prospective
observational

Prospective
observational

Study design

Borger 2002 43

Cook 1996

23

First author

Slow Rewarming

Table 3. Slow vs. fast rewarming: rates, gradients, and outcomes.a
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evaluated for neurocognitive outcomes based on post hoc
rewarming rates. The authors reported a decreased risk of
neurocognitive decline with slow rewarming within one postoperative week, although this advantage was not present at
3 months.
Kawahara et al. (46), in a prospective randomized controlled trial (RCT) of 100 patients, demonstrated a reduction in the decrease in JB venous oxygen saturation with
slow rewarming compared to rapid rewarming; however,
they were unable to demonstrate any biochemical or neurologic benefits. They used similar temperature gradients
as Grigore et al. (45), with a 1 C to 2 C difference between
tympanic membrane and perfusate temperatures in the
slow group (.24 C ± .09 C/min) and a 4 C to 5 C difference in the fast group (.48 C ± .09 C/min).
Sahu et al. (42), in a RCT in which the rewarming rate was
tightly managed with a gradient of 2 C to 4 C, found similar
reductions in JB venous oxygen saturation whether patients
were rewarmed to 37 C or to 33 C. However, the authors
reported less neurocognitive decline in patients rewarmed to
only 33 C. The findings from this study suggest that exposure to cerebral hyperthermia may be associated with rapid
rewarming and increased neurocognitive decline.
Diephuis et al. (44) evaluated the influence of fast
(.5 C/min) and slow (.24 C/min) rewarming rates on cerebral blood flow, measured by transcranial Doppler, finding no significant effect of rewarming on the relation
between pressure and cerebral blood flow. The authors
used a maximal gradient of 10 C between the NP and water
temperature in the fast group and a gradient of 5 C in the
slow rewarming group.
In addition, an advantage associated with slow rewarming
was supported by studies conducted in a pediatric population and in a swine model. Saleh and Barr (47) studied the
effect of three rewarming strategies in pediatric patients and
found that the slowest rewarming rate was associated with
improved indices of cardiac function (improved cardiac index
and decreased lactate production) but was disadvantaged
by longer bypass times and time to reach core temperature
targets. Alam et al. (48), in a swine model of lethal hemorrhage, investigated three rewarming rates from profound
hypothermic arrest, slow (.25 C/min), medium (.5 C/min),
and fast (1 C/min), and found a significant survival advantage in the group that was rewarmed at the medium rate
compared with the fast rate. The group undergoing the slow
rewarming rate had rewarming durations that were 1.7 and
2.1 times as long as those of the medium and fast groups,
respectively, which may account for the worse outcomes in
the slow group compared with those in the medium group.
The Ottawa Heart Institute published a series of reports
discussing neurocognitive findings in two randomized coronary artery bypass grafting trials, each with more than
200 patients. In the first study, patients were randomized
to rapid rewarming either to 37 C or to 34 C. The authors
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reported a significant early cognitive benefit noted in the
relatively hypothermic patients (34,49). In this study arterial
outlet temperatures were not reported nor were the absolute rewarming rates, potentially exposing the normothermic
group to cerebral hyperthermia. Patients in the second
randomized study were maintained at 37 C throughout the
operation or maintained at 34 C without rewarming, thereby
avoiding the rewarming process entirely. The authors found
no differences in neurocognitive function between the
two management strategies (38). They concluded that in
the absence of active rewarming, cerebral hyperthermia
was avoided. Although the conclusion of the two trials
warrants the recommendation to avoid “rapid” rewarming
to 37 C, the actual rate of rewarming in this “rapid” group
was not reported. The data also suggest that normothermia
itself is not associated with neurocognitive decline, but
rather, that rapid rewarming to normothermia may lead
to inadvertent cerebral hyperthermia.
Boodhwani et al. (41) later reported the influence of
rewarming on renal function and concluded that the process of rewarming from 34 C to 37 C on CPB is associated
with increased renal injury. This finding was supported by
Newland et al. (29), who reported an arterial outlet temperature higher than 37 C is an independent predictor of
acute kidney injury.
Multiple authors, including Kaukuntla et al. (50), suggest slow rewarming to avoid heterogeneous changes in
brain temperature, and similarly, Murphy et al. (22) support gradual rewarming compared with rapid rewarming.
Scheffer and Sanders (10) promote slow rewarming for a
number of reasons including 1) avoidance of excess cerebral oxygen extraction and jugular venous desaturation;
2) improved maintenance of the relationship between cerebral blood flow and the cerebral metabolic rate of oxygen;
and 3) increased time for better distribution of heat.
In a review paper comparing hypothermic with normothermic CPB, Grigore et al. (20) highlight the difficulty in
assessing temperature management strategies as distinct
from the confounder of rewarming rate. Only 4 of 15 RCTs
reported information on rewarming rates. Cook (51) summarizes the case for slow rewarming most simply: its adoption increases the likelihood of preventing hyperthermia.
Recommendation:
1. Temperature gradients between the arterial outlet and
venous inflow on the oxygenator during CPB rewarming
should not exceed 10 C to avoid outgassing when warm
blood is returned to the patient. (Class I, Level C)
2. Rewarming when arterial blood outlet temperature ³30 C:
a. To achieve the desired temperature for separation
from bypass, it is reasonable to maintain a temperature gradient between the arterial outlet and the
venous inflow temperature of 4 C or less. (Class IIa,
Level B)
JECT. 2015;47:145–154
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b. To achieve the desired temperature for separation
from bypass, it is reasonable to maintain a rewarming
rate of .5 C/min or less. (Class IIa, Level B)
3. Rewarming when arterial blood outlet temperature is
lower than 30 C: to achieve the desired temperature for
separation from bypass, it is reasonable to maintain a
maximal gradient of 10 C between the arterial outlet
and venous inflow temperature. (Class IIa, Level C)
Optimal Temperature for Weaning from CPB
There have been few compelling studies focused on the
relationship between the temperature at the discontinuation
of CPB and adverse sequelae. In the randomized trial by
Nathan et al. (34) published in 2001, patients were rewarmed
to 37 C or 34 C before CPB was discontinued. Cognitive
function was assessed at three time points: early post-CPB,
3 months, and 5 years. An initial benefit was seen early postCPB in the 34 C group (48% vs. 62% decline), but this was
largely overcome by 3 months, and no statistically significant
benefit was noted by 5 years (34,49,52).
Although it seems that much of the literature supports
a hypothermic separation from CPB to protect cerebral
metabolism, Insler et al. (53) reported outcomes in approximately 1600 coronary artery bypass patients who had core
temperatures lower than 36 C on arrival in the intensive
care unit (ICU). Adjusting for preoperative conditions,
hypothermic patients had increased mortality, more transfusions, increased intubation time, and a longer ICU stay.
An additional consideration in hypothermia is the presence of post-CPB core temperature after drop, which is
associated with reduced blood flow during CPB to muscle

and viscera, and post-CPB heat transfer from the core to
the periphery, resulting in core temperature depression
(54). These are well-known phenomena and have associated morbidities themselves (55). Given the paucity of data
and conflicting literature on weaning temperature and outcome after CPB, no specific weaning temperature is recommended. In the absence of a specific recommendation, the
choice of temperature for weaning from CPB should be
balanced between avoidance of cerebral hyperthermia and
minimization of coagulopathy and transfusion. Post-CPB
surface heating can be used in the postoperative cardiac
surgical patient, but these techniques are not in the purview
of this guideline.
No Recommendation: No specific recommendation for
an optimal temperature for weaning from CPB may be
made due to inconsistent published evidence.
SUMMARY
The importance of accurately recording and reporting
temperature management during CPB cannot be overstated.
Unfortunately, many published articles fail to document temperature management strategies during and after CPB.
Temperature management during CPB remains controversial, with gaps in our knowledge concerning a variety of
aspects of temperature management. The Institute of Medicine has identified the need to incorporate the best clinical
evidence into practice. Importantly, these guidelines challenge the cardiac surgical community to conduct research to

Table 4. Recommendations for temperature management during cardiopulmonary bypass.*
Recommendation
Optimal site for temperature measurement
The oxygenator arterial outlet blood temperature is recommended to be used as a surrogate for cerebral temperature
measurement during CPB
To accurately monitor cerebral perfusate temperature during warming, it should be assumed that the oxygenator
arterial outlet blood temperature underestimates cerebral perfusate temperature
PA catheter or NP temperature recording is reasonable for weaning and immediate postbypass temperature
measurement
Avoidance of hyperthermia
Surgical teams should limit arterial outlet blood temperature to <37 C to avoid cerebral hyperthermia
Peak cooling temperature gradient and cooling rate
Temperature gradients from the arterial outlet and venous inflow on the oxygenator during CPB cooling should not
exceed 10 C to avoid generation of gaseous emboli
Peak warming temperature gradient and rewarming rate
Temperature gradients from the arterial outlet and venous inflow on the oxygenator during CPB rewarming should not
exceed 10 C to avoid outgassing when warm blood is returned to the patient
Rewarming when arterial blood outlet temperature ³30 C
To achieve the desired temperature for separation from bypass, it is reasonable to maintain a temperature gradient
between arterial outlet temperature and the venous inflow of £4 C
To achieve the desired temperature for separation from bypass, it is reasonable to maintain a rewarming rate
of £.5 C/min
Rewarming when arterial blood outlet temperature is <30 C
To achieve the desired temperature for separation from bypass, it is reasonable to maintain a maximal gradient
of 10 C between arterial outlet temperature and venous inflow
*The summary of the recommendations for temperature management during CPB.
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Classification
Class I, Level C
Class I, Level C
Class IIa, Level C
Class I, Level C
Class 1, Level C
Class I, Level C
Class IIa, Level B
Class IIa, Level B
Class IIa, Level C

CLINICAL PRACTICE GUIDELINES FOR CARDIOPULMONARY BYPASS
address these gaps in knowledge. The summary of recommendations for temperature management during CPB is
shown in Table 4.
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APPENDIX
Medical Subject Heading (MeSH) terms used to identify peer-reviewed articles related to temperature management in the setting of adult cardiopulmonary bypass:
(“cardiopulmonary bypass” [MeSH Terms] or perfusion [TIAB]) and (“body temperature” [MeSH Terms] or
“body temperature regulation”[MeSH Terms] or “rewarming” [MeSH Terms]) and (“humans” [MeSH Terms] and
English [lang] and “adult” [MeSH Terms])
((“cardiopulmonary bypass” [MeSH Terms] or cardiopulmonary bypass [TIAB]) and (“hypothermia, induced/
instrumentation” [MAJR:noexp] or “hypothermia, induced/
methods” [MAJR:noexp] or “body temperature” [MeSH
Terms] or “body temperature regulation” [MeSH Terms]
or “rewarming”[MeSH Terms]) and (“humans”[MeSH
Terms] and English [lang])) not ((“cardiopulmonary
bypass”[MeSH Terms] or perfusion [TIAB]) and (“body
temperature” [MeSH Terms] or “body temperature regulation” [MeSH Terms] or “rewarming” [MeSH Terms]) and
(“humans” [MeSH Terms] and English [lang] and “adult”
[MeSH Terms])).

